Fig 1: Markers of erythropoiesis in uninfected children and children with resolved or persistent P. falciparum infections. Concentrations of soluble proteins in plasma for (A) Haem, (B) Haemopexin (HPX), (C) haemoxygenase-1 (HO-1), (D) soluble CD163, (E) erythropoietin (EPO), (F) Ferritin (iron load), and (G) Transferrin (ferric-ion delivery). Data shown as box plots with min/max whiskers where dots represent each participant. Significant p values shown, calculated using a Kruskal-Wallis rank sum test followed by a post-hoc Dunn’s test with Bonferroni adjustment for multiple comparisons. Group IDs: #1 ‘Controls’, #2 ‘Anaemic’, #3 ‘Resolved’, and #4 ‘Chronic’.
Fig 2: Aggregated (a,c,e) and individual (b,d,f) data on cell-free hemoglobin (a,b), haptoglobin (c,d) and hemopexin (e,f) concentrations during the study period. The shaded area represents the interquartile range of concentrations of respective protein in prime solution. Hb = hemoglobin, Hp = haptoglobin, Hpx = hemopexin, pre = preoperative sampling, t00–t04 = hourly sampling during CPB circulation, post = sampling after bypass separation, pod0 = admission to pediatric intensive care unit after surgery, pod1–3 = postoperative day 1–3.
Supplier Page from Aviva Systems Biology for Hemopexin ELISA Kit (Human) (OKIA00066)
Homology: Human